327
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype

&
Pages 2314-2320 | Received 14 May 2012, Accepted 19 May 2012, Published online: 09 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Claire E Bocchini, Moses M Kasembeli, Soung-Hun Roh & David J Tweardy. (2014) Contribution of chaperones to STAT pathway signaling. JAK-STAT 3:3.
Read now

Articles from other publishers (9)

Chun-Xia He, You Lv, Meng Guo, Huan Zhou, Wei Qin, Dong Zhao, Hui-Jin Li, Lu Xing, Xin Zhou, Peng-Quan Li, Feng Yu, Jian-Hua He & Hui-Ling Cao. (2022) Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922. Frontiers in Oncology 12.
Crossref
Zarema Albakova, Yana Mangasarova & Alexander Sapozhnikov. (2021) Heat Shock Proteins in Lymphoma Immunotherapy. Frontiers in Immunology 12.
Crossref
Thu-Huyen Pham, Hyo-Min Park, Jinju Kim, Jin Tae Hong & Do-Young Yoon. (2020) STAT3 and p53: Dual Target for Cancer Therapy. Biomedicines 8:12, pages 637.
Crossref
Timothy L. Chen, Nikhil Gupta, Amy Lehman, Amy S. Ruppert, Lianbo Yu, Christopher C. Oakes, Rainer Claus, Christoph Plass, Kami J. Maddocks, Leslie Andritsos, Jeffery A. Jones, David M. Lucas, Amy J. Johnson, John C. Byrd & Erin Hertlein. (2016) Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia. Oncotarget 7:19, pages 28684-28696.
Crossref
Torunn Wendel, Yan Zhen, Zenhe Suo, Skjalg Bruheim & Antoni Wiedlocha. (2016) The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo. Experimental Cell Research 340:2, pages 220-226.
Crossref
Ana E Rodríguez-Vicente, Dalia Quwaider, Rocío Benito, Irena Misiewicz-Krzeminska, María Hernández-Sánchez, Alfonso García de Coca, Rosa Fisac, José-María Alonso, Carolina Zato, Juan Francisco de Paz, Juan Luis García, Ma Eugenia Sarasquete, José Ángel Hernández, Juan M Corchado, Marcos González, Norma C Gutiérrez & Jesús-María Hernández-Rivas. (2015) MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL. BMC Cancer 15:1.
Crossref
Zuzana Sol�rov�, J�n Mojžiš & Peter Sol�r. (2014) Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review). International Journal of Oncology.
Crossref
Si-Meng Chen, Chen-Liang Guo, Jia-Jie Shi, Yi-Chao Xu, Yi Chen, Yan-Yan Shen, Yi Su, Jian Ding & Ling-Hua Meng. (2014) HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer. International Journal of Cancer 135:10, pages 2462-2474.
Crossref
Martin Trbusek & Jitka Malcikova. 2013. Advances in Chronic Lymphocytic Leukemia. Advances in Chronic Lymphocytic Leukemia 109 131 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.